This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsSteep Hill（CD0）株式概要スティープ・ヒル社には重要な事業はない。 詳細CD0 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析株式の流動性は非常に低い 収益が 100 万ドル未満 ( CA$0 )意味のある時価総額がありません ( €551K )すべてのリスクチェックを見るCD0 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.029該当なし内在価値ディスカウントEst. Revenue$PastFuture-4m1m2016201920222025202620282031Revenue CA$0.3Earnings CA$0.05AdvancedSet Fair ValueView all narrativesSteep Hill Inc. 競合他社EpigenomicsSymbol: DB:ECXMarket cap: €763.0kBiofronteraSymbol: XTRA:B8FKMarket cap: €14.7mbioXXmedSymbol: XTRA:T5O0Market cap: €329.8kCaptor CapitalSymbol: CNSX:CPTRMarket cap: CA$767.1k価格と性能株価の高値、安値、推移の概要Steep Hill過去の株価現在の株価CA$0.02952週高値CA$0.03952週安値CA$0.012ベータ1.871ヶ月の変化0%3ヶ月変化-12.12%1年変化-14.71%3年間の変化286.72%5年間の変化n/aIPOからの変化-86.67%最新ニュースお知らせ • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.お知らせ • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.お知らせ • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.お知らせ • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.お知らせ • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.お知らせ • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.最新情報をもっと見るRecent updatesお知らせ • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.お知らせ • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.お知らせ • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.お知らせ • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.お知らせ • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.お知らせ • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.Board Change • Jul 26High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. 2 experienced directors. No highly experienced directors. Independent Director Ian Morton is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.New Risk • Jun 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€326.3k market cap, or US$354.5k).お知らせ • Apr 24Steep Hill Inc., Annual General Meeting, Jul 26, 2024Steep Hill Inc., Annual General Meeting, Jul 26, 2024.New Risk • Apr 17New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (67% average weekly change). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€275.4k market cap, or US$293.9k).Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).お知らせ • Jul 06Steep Hill Inc. Announces Demise of Director, David WaltersThe Board of Directors and management of Steep Hill Inc. announce that Director, David Walters, has passed away. David joined the board at the time of the go-public transaction of Canbud Distribution Corp., (now called Steep Hill Inc) and during his time with the company provided oversight as Audit Committee chair. On behalf of the Board of Directors and team, company extend the deepest condolences to David's family and to all those who came to know him as a colleague and as a friend.お知らせ • Jun 04Steep Hill Inc. Announces Chief Financial Officer ChangeSteep Hill Inc. announced that Raj Ravindran has resigned as the company's Chief Financial Officer to pursue other endeavors. Raj was one of the co-founders of Canbud Distribution Corp., the entity that culminated into Steep Hill following the acquisitions made in 2021 and 2022. The board announced the appointment of Ms. Patricia Militello as Interim CFO. Since fourth quarter of 2021, Ms. Militello has been instrumental in leading the finance and accounting team as an external consultant. Ms. Militello is expected to lend her expertise as Steep Hill continues on the path of restructuring and exploring strategic alternatives.お知らせ • May 19Steep Hill Inc., Annual General Meeting, Jul 28, 2023Steep Hill Inc., Annual General Meeting, Jul 28, 2023.Board Change • Dec 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 3 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Mar 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.株主還元CD0DE PharmaceuticalsDE 市場7D0%6.1%3.2%1Y-14.7%27.3%2.5%株主還元を見る業界別リターン: CD0過去 1 年間で27.3 % の収益を上げたGerman Pharmaceuticals業界を下回りました。リターン対市場: CD0は、過去 1 年間で2.5 % のリターンを上げたGerman市場を下回りました。価格変動Is CD0's price volatile compared to industry and market?CD0 volatilityCD0 Average Weekly Movementn/aPharmaceuticals Industry Average Movement6.4%Market Average Movement6.1%10% most volatile stocks in DE Market13.3%10% least volatile stocks in DE Market2.7%安定した株価: CD0の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のCD0のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2008n/aSameet Kanadewww.steephill.comスティープヒル社は重要な事業を行っていない。以前はカナダで大麻科学会社として営業していた。同社は以前はCanbud Distribution Corp.として知られていたが、2022年2月に社名をSteep Hill Inc.に変更した。同社は2008年に設立され、カナダのトロントを拠点としている。もっと見るSteep Hill Inc. 基礎のまとめSteep Hill の収益と売上を時価総額と比較するとどうか。CD0 基礎統計学時価総額€550.79k収益（TTM）-€138.46k売上高(TTM)n/a0.0xP/Sレシオ-4.0xPER（株価収益率CD0 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計CD0 損益計算書（TTM）収益CA$0売上原価CA$0売上総利益CA$0その他の費用CA$223.70k収益-CA$223.70k直近の収益報告Sep 30, 2025次回決算日該当なし一株当たり利益（EPS）-0.014グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0%CD0 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/02/10 12:12終値2025/11/13 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Steep Hill Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.
お知らせ • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.
お知らせ • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.
お知らせ • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.
お知らせ • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.
お知らせ • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.
お知らせ • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.
お知らせ • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.
お知らせ • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.
お知らせ • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.
お知らせ • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.
お知らせ • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.
Board Change • Jul 26High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. 2 experienced directors. No highly experienced directors. Independent Director Ian Morton is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
New Risk • Jun 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€326.3k market cap, or US$354.5k).
お知らせ • Apr 24Steep Hill Inc., Annual General Meeting, Jul 26, 2024Steep Hill Inc., Annual General Meeting, Jul 26, 2024.
New Risk • Apr 17New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (67% average weekly change). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€275.4k market cap, or US$293.9k).
Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).
Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).
お知らせ • Jul 06Steep Hill Inc. Announces Demise of Director, David WaltersThe Board of Directors and management of Steep Hill Inc. announce that Director, David Walters, has passed away. David joined the board at the time of the go-public transaction of Canbud Distribution Corp., (now called Steep Hill Inc) and during his time with the company provided oversight as Audit Committee chair. On behalf of the Board of Directors and team, company extend the deepest condolences to David's family and to all those who came to know him as a colleague and as a friend.
お知らせ • Jun 04Steep Hill Inc. Announces Chief Financial Officer ChangeSteep Hill Inc. announced that Raj Ravindran has resigned as the company's Chief Financial Officer to pursue other endeavors. Raj was one of the co-founders of Canbud Distribution Corp., the entity that culminated into Steep Hill following the acquisitions made in 2021 and 2022. The board announced the appointment of Ms. Patricia Militello as Interim CFO. Since fourth quarter of 2021, Ms. Militello has been instrumental in leading the finance and accounting team as an external consultant. Ms. Militello is expected to lend her expertise as Steep Hill continues on the path of restructuring and exploring strategic alternatives.
お知らせ • May 19Steep Hill Inc., Annual General Meeting, Jul 28, 2023Steep Hill Inc., Annual General Meeting, Jul 28, 2023.
Board Change • Dec 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 3 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Mar 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
